Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease.
about
Inflammatory bowel disease surgery in the biologic eraSurgical Principles in the Treatment of Ulcerative ColitisAnti-Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position PaperA review of the impact of biologics on surgical complications in Crohn's diseaseAdverse events in IBD: to stop or continue immune suppressant and biologic treatmentTherapeutic peptides in inflammatory bowel disease.Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis.Surgery in the age of biological treatment.Management of severe ulcerative colitis.Systematic Review: Sequential Rescue Therapy in Severe Ulcerative Colitis: Do the Benefits Outweigh the Risks?Safety of Anti-TNF Therapies in Immune-Mediated Inflammatory Diseases: Focus on Infections and Malignancy.Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease.Medical versus surgical management of penetrating Crohn's disease: the current situation and future perspectives.Association of Preoperative Anti-Tumor Necrosis Factor Therapy With Adverse Postoperative Outcomes in Patients Undergoing Abdominal Surgery for Ulcerative Colitis.Total abdominal colectomy vs. restorative total proctocolectomy as the initial approach to medically refractory ulcerative colitis.Post-operative abdominal complications in Crohn's disease in the biological era: Systematic review and meta-analysis.Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients.Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls.Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.Cost of Ulcerative Colitis in Quebec, Canada: A Retrospective Cohort Study.Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.The effect of pre-operative optimization on post-operative outcome in Crohn's disease resections.Perioperative Blood Transfusion and Postoperative Outcome in Patients with Crohn's Disease Undergoing Primary Ileocolonic Resection in the "Biological Era".The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease.Pushing the pedal to the metal: should we accelerate infliximab therapy for patients with severe ulcerative colitis?Response to Kotze et al.Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease.Ileocecal Resection in Crohn's Disease: REMIND Group Study.Recent trends (2016-2017) in the treatment of inflammatory bowel disease.Recent advances and emerging therapies in the non-surgical management of ulcerative colitis
P2860
Q26745627-32A386BE-2634-47D6-A371-82B37275BC80Q26777727-19096FC1-8CC6-40FA-9F87-F5DD859BC5B0Q26783978-199E6AB9-00E7-4414-8369-D07BBD86F7F1Q26865009-83BA301A-A541-48E9-989D-C57D60C05BC1Q34073191-90413064-51C5-4CA7-ADF0-7799D6C0EDE3Q38180807-3400B380-7291-4AED-BC6B-2294BB8B1225Q38291763-7467525F-5A43-4619-91F0-F23B25593F6AQ38293805-6E03FEB1-00B4-40B3-9762-1D08E8BE7A15Q38321528-079B40FE-679F-44F4-BB3A-0CBB3B6ACCEFQ38404037-8499D9F9-5C63-423D-AB70-F856C35574BBQ38611360-64D6C00D-A0BE-4608-AEA0-C7464CD62F7FQ38647797-A56D9922-CDF3-491B-9680-5BCC8DFF36F9Q38668874-70DDBAAB-D042-4D29-B0E1-BC8CA13B1982Q38725724-6D1CCCD5-8B36-4EC7-A2C4-B5C95FBD6BE6Q38769696-24CF9A1F-B09F-4645-BF37-34570736B32EQ38791996-E88EC918-2268-448E-A0E5-CC1869DDB93CQ38820319-BDFCFE46-7A8B-469F-9AD5-02DB39215401Q39106087-463004F5-5BEC-48B4-B260-55ABD236D50AQ39316824-B77D8B63-3489-4BBD-A6F1-E6262E592907Q40072921-9CB046BB-63D0-485E-9C4A-DB8D32E3F5A1Q40129641-1B17DE0B-A9C4-4ABF-8293-17EE3DEA7341Q40416993-9A58F325-8AF9-4EBE-A9FB-FCABF300D430Q40482612-788575B6-FD42-486A-BB3E-7E1BBB26F29CQ40629402-5FAF9D4E-3346-4FCB-A27D-EE1BC41F2466Q42202561-FF1F4858-CFDD-407C-BA9B-47768F449BF7Q43190589-042FB95B-D679-4EF8-A6D2-1928DE2BD8BFQ44648018-648CC9F6-44F6-4C39-B85E-A8A392D575CEQ46989239-D99AADEC-EC63-4577-BE20-FC0EC29CD430Q50218913-E69F51EA-EF15-419B-991B-4AA715594FF1Q55690193-F98432E2-7BE1-4C6D-8ED8-C31ECC33B843Q57170397-C538E650-D593-418B-8C15-754E841BB946
P2860
Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Meta-analysis: peri-operative ...... th inflammatory bowel disease.
@en
type
label
Meta-analysis: peri-operative ...... th inflammatory bowel disease.
@en
prefLabel
Meta-analysis: peri-operative ...... th inflammatory bowel disease.
@en
P2093
P2860
P356
P1476
Meta-analysis: peri-operative ...... th inflammatory bowel disease.
@en
P2093
D Charleton
J K Marshall
P2860
P304
P356
10.1111/APT.12313
P407
P577
2013-04-14T00:00:00Z